INDUSTRY OVERVIEW
The Point of Care Testing is Growing at 9.50% and is expected to reach 50Billion by 2030. Below mentioned are some of the dynamics shaping the Point of Care Testing .Point of Care Testing Market Size in (USD Billion) CAGR Growth Rate 9.50%
| Study Period | 2024-2030 |
| Market Size (2019): | 25Billion |
| Market Size (2030): | 50Billion |
| CAGR (2019 - 2030): | 9.50% |
| Fastest Growing Region | North America |
| Dominating Region | North America |
www.www.htfmarketinsights.com
The Point of Care Testing (POCT) market refers to diagnostic tests conducted at or near the site of patient care, providing rapid results for medical conditions such as infectious diseases, glucose levels, cholesterol, and pregnancy. POCT devices are increasingly popular due to their ability to deliver fast and reliable results, often reducing the need for patients to visit centralized laboratories. The market is driven by the growing demand for quick diagnoses, increased healthcare awareness, and the shift towards home-based and remote healthcare. Technological advancements, including portable and user-friendly devices, and the increasing prevalence of chronic diseases and infections, further support market growth. POCT allows for more efficient and cost-effective healthcare delivery, especially in settings like hospitals, clinics, and even home care environments. The market is also expanding with the rise of mobile health and telemedicine solutions that integrate POCT devices.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- Improving Access To Diagnostics And Patient Care
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- Test Accuracy
- Quality Control
- Regulatory Compliance
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- Mobile POCT Devices
- Connected Devices
- Data Management Systems
Market Opportunities:
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Improving Access To Diagnostics And Patient Care
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- Blood Glucose Meters
- Pregnancy Tests
- Rapid Diagnostic Tests (RDTs)
- Blood Gas Analyzers
Point of Care Testing Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Diagnostics
- Healthcare
- Home Healthcare
- Emergency Medicine
- Critical Care
Point of Care Testing Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The North America currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, North America is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
North America
Dominating Region
North America
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- Abbott
- Roche Diagnostics
- Siemens Healthineers
- Danaher
- Becton Dickinson
- Thermo Fisher Scientific
- Quidel
- Cepheid
- EKF Diagnostics
- Bio-Rad Laboratories
- Nova Biomedical
- OraSure Technologies
- Abaxis
- Sysmex
Point of Care Testing Market Segmentation by Players
www.htfmarketinsights.com
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2019 |
|
Based Year Market Size (2023) |
25Billion |
|
Historical Period |
2024 to 2019 |
|
CAGR (2019 to 2030) |
9.50% |
|
Forecast Period |
2019 to 2030 |
|
Forecasted Period Market Size (2030) |
50Billion |
|
Scope of the Report |
Segmentation by Type Blood Glucose Meters, Pregnancy Tests, Rapid Diagnostic Tests (RDTs), Blood Gas Analyzers, Segmentation by Application Diagnostics, Healthcare, Home Healthcare, Emergency Medicine, Critical Care, Sales Channel |
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
Abbott, Roche Diagnostics, Siemens Healthineers, Danaher, Becton Dickinson, Thermo Fisher Scientific, Quidel, Cepheid, EKF Diagnostics, Bio-Rad Laboratories, Nova Biomedical, OraSure Technologies, Abaxis, Sysmex |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
Point of Care Testing - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Point of Care Testing Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Point of Care Testing Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Point of Care Testing Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Improving Access to Diagnostics and Patient Care
-
3.2 Available Opportunities
- 3.2.1 Improving Access to Diagnostics and Patient Care
-
3.3 Influencing Trends
- 3.3.1 Mobile POCT Devices
- 3.3.2 Connected Devices
- 3.3.3 Data Management Systems
- 3.3.4 Multiplex Assays
-
3.4 Challenges
- 3.4.1 Test Accuracy
- 3.4.2 Quality Control
- 3.4.3 Regulatory Compliance
- 3.4.4 Data Management
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Point of Care Testing Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Point of Care Testing Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: Point of Care Testing : Competition Benchmarking & Performance Evaluation
- 5.1 Global Point of Care Testing Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Point of Care Testing Revenue 2019
- 5.3 Global Point of Care Testing Sales Volume by Manufacturers (2019)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 Heat Map Analysis
- 5.6 Strategic Group Analysis
Chapter 6: Global Point of Care Testing Market: Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Overview
- 6.1.2 Abbott Product/Service Portfolio & Specifications
- 6.1.3 Abbott Key Financial Metrics
- 6.1.4 Abbott SWOT Analysis
- 6.1.5 Abbott Development Activities
- 6.2 Roche Diagnostics
- 6.3 Siemens Healthineers
- 6.4 Danaher
- 6.5 Becton Dickinson
- 6.6 Thermo Fisher Scientific
- 6.7 Quidel
- 6.8 Cepheid
- 6.9 EKF Diagnostics
- 6.10 Bio-Rad Laboratories
- 6.11 Nova Biomedical
- 6.12 OraSure Technologies
- 6.13 Abaxis
- 6.14 Sysmex
- 6.15 Instrumentation Laboratory
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Point of Care Testing by Type & Application (2024-2030)
-
7.1 Global Point of Care Testing Market Revenue Analysis (USD Million) by Type (2024-2019)
- 7.1.1 Blood Glucose Meters
- 7.1.2 Pregnancy Tests
- 7.1.3 Rapid Diagnostic Tests (RDTs)
- 7.1.4 Blood Gas Analyzers
- 7.1.5 Coagulation Analyzers
-
7.2 Global Point of Care Testing Market Revenue Analysis (USD Million) by Application (2024-2019)
- 7.2.1 Diagnostics
- 7.2.2 Healthcare
- 7.2.3 Home Healthcare
- 7.2.4 Emergency Medicine
- 7.2.5 Critical Care
- 7.3 Global Point of Care Testing Market Revenue Analysis (USD Million) by Type (2019-2030)
- 7.4 Global Point of Care Testing Market Revenue Analysis (USD Million) by Application (2019-2030)
Chapter 8 : North America Point of Care Testing Market Breakdown by Country, Type & Application
- 8.1 North America Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 8.2.1 Blood Glucose Meters
- 8.2.2 Pregnancy Tests
- 8.2.3 Rapid Diagnostic Tests (RDTs)
- 8.2.4 Blood Gas Analyzers
- 8.2.5 Coagulation Analyzers
-
8.3 North America Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 8.3.1 Diagnostics
- 8.3.2 Healthcare
- 8.3.3 Home Healthcare
- 8.3.4 Emergency Medicine
- 8.3.5 Critical Care
- 8.4 North America Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 8.5 North America Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 8.6 North America Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Point of Care Testing Market Breakdown by Country, Type & Application
- 9.1 LATAM Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 9.2.1 Blood Glucose Meters
- 9.2.2 Pregnancy Tests
- 9.2.3 Rapid Diagnostic Tests (RDTs)
- 9.2.4 Blood Gas Analyzers
- 9.2.5 Coagulation Analyzers
-
9.3 LATAM Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 9.3.1 Diagnostics
- 9.3.2 Healthcare
- 9.3.3 Home Healthcare
- 9.3.4 Emergency Medicine
- 9.3.5 Critical Care
- 9.4 LATAM Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 9.5 LATAM Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 9.6 LATAM Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 10 : West Europe Point of Care Testing Market Breakdown by Country, Type & Application
- 10.1 West Europe Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 10.2.1 Blood Glucose Meters
- 10.2.2 Pregnancy Tests
- 10.2.3 Rapid Diagnostic Tests (RDTs)
- 10.2.4 Blood Gas Analyzers
- 10.2.5 Coagulation Analyzers
-
10.3 West Europe Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 10.3.1 Diagnostics
- 10.3.2 Healthcare
- 10.3.3 Home Healthcare
- 10.3.4 Emergency Medicine
- 10.3.5 Critical Care
- 10.4 West Europe Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 10.5 West Europe Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 10.6 West Europe Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 11 : Central & Eastern Europe Point of Care Testing Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 11.2.1 Blood Glucose Meters
- 11.2.2 Pregnancy Tests
- 11.2.3 Rapid Diagnostic Tests (RDTs)
- 11.2.4 Blood Gas Analyzers
- 11.2.5 Coagulation Analyzers
-
11.3 Central & Eastern Europe Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 11.3.1 Diagnostics
- 11.3.2 Healthcare
- 11.3.3 Home Healthcare
- 11.3.4 Emergency Medicine
- 11.3.5 Critical Care
- 11.4 Central & Eastern Europe Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 11.5 Central & Eastern Europe Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 11.6 Central & Eastern Europe Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 12 : Northern Europe Point of Care Testing Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 12.2.1 Blood Glucose Meters
- 12.2.2 Pregnancy Tests
- 12.2.3 Rapid Diagnostic Tests (RDTs)
- 12.2.4 Blood Gas Analyzers
- 12.2.5 Coagulation Analyzers
-
12.3 Northern Europe Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 12.3.1 Diagnostics
- 12.3.2 Healthcare
- 12.3.3 Home Healthcare
- 12.3.4 Emergency Medicine
- 12.3.5 Critical Care
- 12.4 Northern Europe Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 12.5 Northern Europe Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 12.6 Northern Europe Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 13 : Southern Europe Point of Care Testing Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 13.2.1 Blood Glucose Meters
- 13.2.2 Pregnancy Tests
- 13.2.3 Rapid Diagnostic Tests (RDTs)
- 13.2.4 Blood Gas Analyzers
- 13.2.5 Coagulation Analyzers
-
13.3 Southern Europe Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 13.3.1 Diagnostics
- 13.3.2 Healthcare
- 13.3.3 Home Healthcare
- 13.3.4 Emergency Medicine
- 13.3.5 Critical Care
- 13.4 Southern Europe Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 13.5 Southern Europe Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 13.6 Southern Europe Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 14 : East Asia Point of Care Testing Market Breakdown by Country, Type & Application
- 14.1 East Asia Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 14.2.1 Blood Glucose Meters
- 14.2.2 Pregnancy Tests
- 14.2.3 Rapid Diagnostic Tests (RDTs)
- 14.2.4 Blood Gas Analyzers
- 14.2.5 Coagulation Analyzers
-
14.3 East Asia Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 14.3.1 Diagnostics
- 14.3.2 Healthcare
- 14.3.3 Home Healthcare
- 14.3.4 Emergency Medicine
- 14.3.5 Critical Care
- 14.4 East Asia Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 14.5 East Asia Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 14.6 East Asia Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 15 : Southeast Asia Point of Care Testing Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 15.2.1 Blood Glucose Meters
- 15.2.2 Pregnancy Tests
- 15.2.3 Rapid Diagnostic Tests (RDTs)
- 15.2.4 Blood Gas Analyzers
- 15.2.5 Coagulation Analyzers
-
15.3 Southeast Asia Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 15.3.1 Diagnostics
- 15.3.2 Healthcare
- 15.3.3 Home Healthcare
- 15.3.4 Emergency Medicine
- 15.3.5 Critical Care
- 15.4 Southeast Asia Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 15.5 Southeast Asia Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 15.6 Southeast Asia Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 16 : South Asia Point of Care Testing Market Breakdown by Country, Type & Application
- 16.1 South Asia Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 16.2.1 Blood Glucose Meters
- 16.2.2 Pregnancy Tests
- 16.2.3 Rapid Diagnostic Tests (RDTs)
- 16.2.4 Blood Gas Analyzers
- 16.2.5 Coagulation Analyzers
-
16.3 South Asia Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 16.3.1 Diagnostics
- 16.3.2 Healthcare
- 16.3.3 Home Healthcare
- 16.3.4 Emergency Medicine
- 16.3.5 Critical Care
- 16.4 South Asia Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 16.5 South Asia Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 16.6 South Asia Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 17 : Central Asia Point of Care Testing Market Breakdown by Country, Type & Application
- 17.1 Central Asia Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 17.2.1 Blood Glucose Meters
- 17.2.2 Pregnancy Tests
- 17.2.3 Rapid Diagnostic Tests (RDTs)
- 17.2.4 Blood Gas Analyzers
- 17.2.5 Coagulation Analyzers
-
17.3 Central Asia Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 17.3.1 Diagnostics
- 17.3.2 Healthcare
- 17.3.3 Home Healthcare
- 17.3.4 Emergency Medicine
- 17.3.5 Critical Care
- 17.4 Central Asia Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 17.5 Central Asia Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 17.6 Central Asia Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 18 : Oceania Point of Care Testing Market Breakdown by Country, Type & Application
- 18.1 Oceania Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 18.2.1 Blood Glucose Meters
- 18.2.2 Pregnancy Tests
- 18.2.3 Rapid Diagnostic Tests (RDTs)
- 18.2.4 Blood Gas Analyzers
- 18.2.5 Coagulation Analyzers
-
18.3 Oceania Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 18.3.1 Diagnostics
- 18.3.2 Healthcare
- 18.3.3 Home Healthcare
- 18.3.4 Emergency Medicine
- 18.3.5 Critical Care
- 18.4 Oceania Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 18.5 Oceania Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 18.6 Oceania Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 19 : MEA Point of Care Testing Market Breakdown by Country, Type & Application
- 19.1 MEA Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 19.2.1 Blood Glucose Meters
- 19.2.2 Pregnancy Tests
- 19.2.3 Rapid Diagnostic Tests (RDTs)
- 19.2.4 Blood Gas Analyzers
- 19.2.5 Coagulation Analyzers
-
19.3 MEA Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 19.3.1 Diagnostics
- 19.3.2 Healthcare
- 19.3.3 Home Healthcare
- 19.3.4 Emergency Medicine
- 19.3.5 Critical Care
- 19.4 MEA Point of Care Testing Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 19.5 MEA Point of Care Testing Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 19.6 MEA Point of Care Testing Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Global Point of Care Testing market is estimated to see a CAGR of 9.50% and may reach an estimated market size of 9.50% 50 billion by 2030.
The Point of Care Testing Market is growing at a CAGR of 9.50% over the forecasted period 2019 - 2030.
The changing dynamics and trends such as Mobile POCT Devices, Connected Devices, Data Management Systems, Multiplex Assays are seen as major Game Changer in Global Point of Care Testing Market.
- Improving Access To Diagnostics And Patient Care
As Industry players prepare to scale up, Point of Care Testing Market sees major concern such as Test Accuracy, Quality Control, Regulatory Compliance, Data Management.
The market opportunity is clear from the flow of investment into Global Point of Care Testing Market, some of them are Improving Access To Diagnostics And Patient Care.
Point of Care Testing Market identifies market share by players along with the concentration rate using CR4, CR8 Index to determine leading and emerging competitive players such as Abbott, Roche Diagnostics, Siemens Healthineers, Danaher, Becton Dickinson, Thermo Fisher Scientific, Quidel, Cepheid, EKF Diagnostics, Bio-Rad Laboratories, Nova Biomedical, OraSure Technologies, Abaxis, Sysmex, Instrumentation Laboratory.
Research paper of Global Point of Care Testing Market shows that companies are making better progress than their supply chain peers –including suppliers, majorly in end-use applications such as Diagnostics, Healthcare, Home Healthcare, Emergency Medicine, Critical Care.
The Global Point of Care Testing Market Study is segmented by Blood Glucose Meters, Pregnancy Tests, Rapid Diagnostic Tests (RDTs), Blood Gas Analyzers, Coagulation Analyzers.
The Global Point of Care Testing Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
Historical Year: 2024 - Base year: 2019. Forecast period**: 2025 to 2030 [** unless otherwise stated]
The Point of Care Testing (POCT) market refers to diagnostic tests conducted at or near the site of patient care, providing rapid results for medical conditions such as infectious diseases, glucose levels, cholesterol, and pregnancy. POCT devices are increasingly popular due to their ability to deliver fast and reliable results, often reducing the need for patients to visit centralized laboratories. The market is driven by the growing demand for quick diagnoses, increased healthcare awareness, and the shift towards home-based and remote healthcare. Technological advancements, including portable and user-friendly devices, and the increasing prevalence of chronic diseases and infections, further support market growth. POCT allows for more efficient and cost-effective healthcare delivery, especially in settings like hospitals, clinics, and even home care environments. The market is also expanding with the rise of mobile health and telemedicine solutions that integrate POCT devices.
